Beijing Tsinghua Chang Gung Hospital
Clinical trials sponsored by Beijing Tsinghua Chang Gung Hospital, explained in plain language.
-
Heated chemo showdown: is more always better for rare abdominal cancer?
Disease control Recruiting nowThis study aims to find out if receiving three sessions of heated chemotherapy (HIPEC) after major abdominal surgery works better and is as safe as receiving just one session for patients with a rare abdominal cancer called pseudomyxoma peritonei. Researchers will randomly assign…
Phase: NA • Sponsor: Beijing Tsinghua Chang Gung Hospital • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
Lab-Grown tumor models test drugs before patients get them
Disease control Recruiting nowThis study is testing a personalized approach to treat a rare abdominal cancer called peritoneal mesothelioma. Researchers will grow a small model of a patient's tumor in the lab and test different drugs on it to see which works best before giving it to the patient. The goal is t…
Phase: NA • Sponsor: Beijing Tsinghua Chang Gung Hospital • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC
-
Can we predict a silent heart attack after surgery?
Diagnosis Recruiting nowThis study aims to develop a prediction tool to identify which patients undergoing major liver or bile duct surgery are at high risk for a specific type of heart injury that can occur after the operation. Researchers will collect data from 1,800 patients, including their health h…
Sponsor: Beijing Tsinghua Chang Gung Hospital • Aim: Diagnosis
Last updated Apr 02, 2026 14:57 UTC